TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Campus Pharma AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
262,527
|
209,853
|
175,079 |
| Financial expenses |
650
|
1,346
|
1,196 |
| Earnings before taxes |
29,139
|
-5,091
|
-9,465 |
| EBITDA |
45,388
|
22,422
|
17,429 |
| Total assets |
112,205
|
133,289
|
119,402 |
| Current assets |
105,749
|
107,698
|
71,161 |
| Current liabilities |
63,411
|
69,720
|
51,165 |
| Equity capital |
48,731
|
62,563
|
68,237 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
43
|
38
|
30 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
43.4%
|
46.9%
|
57.1% |
| Turnover per employee |
6,105
|
5,522
|
5,836 |
| Profit as a percentage of turnover |
11.1%
|
-2.4%
|
-5.4% |
| Return on assets (ROA) |
26.5%
|
-2.8%
|
-6.9% |
| Current ratio |
166.8%
|
154.5%
|
139.1% |
| Return on equity (ROE) |
59.8%
|
-8.1%
|
-13.9% |
| Change turnover |
52,674
|
34,774
|
6,726 |
| Change turnover % |
25%
|
20%
|
4% |
| Chg. No. of employees |
5
|
8
|
3 |
| Chg. No. of employees % |
13%
|
27%
|
11% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.